Latest News

You can find our latest news below

31 Aug, 2016
During the first half of 2016, HyTest was able to continue its strong growth. Its...
31 Aug, 2016
BNP and NT-proBNP are widely accepted biomarkers of heart failure. However, we...
16 Aug, 2016
We will be present at the ECVIM-CA congress, which is held in Svenska Massan...
14 Jul, 2016
We provide five in vitro-produced monoclonal antibodies that are specific to human Lp-PLA2. They can be used for the development of quantitative immunoassays which enable the detection of Lp-PLA2 from plasma samples. In addition, we provide recombinant human Lp-PLA2.
08 Jul, 2016
HyTest will be participating the 2016 AACC Annual Meeting & Clinical Lab Expo.
31 May, 2016
A recently introduced heart failure drug Entresto™ (LCZ696) has been suggested to increase...
30 May, 2016
We will be present at the Forum of American College of Veterinary Internal Medicine...
26 Apr, 2016
Despite the global economic challenges, HyTest was able to grow corporate sales by...
26 Apr, 2016
We are delighted to announce that Prof. Fred S. Apple joined the HyTest Board of Directors in April 2016.
30 Mar, 2016
HyTest participates the CMEF in Shanghai, China on April 17-20, 2016.
25 Feb, 2016
HyTest participates in the 13th China Association of Clinical Laboratory Practice Expo held in Qujiang International Conference & Exhibition Center, Xi’an, 7 – 9, March.
17 Dec, 2015
Thank you for being part of our year!
28 Oct, 2015
HyTest participates in MEDICA 2015 - the World's Leading Medical Forum - from November 16 to19.
21 Oct, 2015
On the 19th October Maria Severina was chosen as a regional winner of West Finland in the category production.
29 Sep, 2015
The newly FDA-approved heart failure drug (Entresto®) has caused significant excitement as the clinical studies have shown considerably better therapy outcomes for patients suffering from heart failure.
01 Sep, 2015
HyTest was able to continue its strong growth during the first half of 2015. Consolidated revenue grew to 9.2 million euros, which represented an increase of 18% compared to the first half of the previous year.
23 Jun, 2015
We are delighted to announce the news that HyTest has been granted a patent in the United States for SES-BNP technology and IGFBP-4 fragments in Finland, France, Germany, Sweden and the United Kingdom.
17 Jun, 2015
Our new MAbs and antigens allow detection of CRP in dogs and SAA in dogs, cats and horses.
21 May, 2015
In July 26-30 HyTest will be participating the 2015 AACC Annual Meeting & Clinical Lab Expo
05 May, 2015
HyTest has been growing steadily throughout its 20 year history and 2014 was no exception. HyTest’s revenue grew to 16.3 million euros.

Do you need samples?

We are happy to make you an offer